Skip to main content

Advertisement

SpringerLink
Log in

Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To assess longitudinally the course and outcome of juvenile idiopathic arthritis (JIA) in patients diagnosed and followed-up exclusively in the biologic era; also, to define possible predictors of the disease progression and need for early implementation of biologicals. Prospective and retrospective, monocentric cohort study of 120 JIA patients, diagnosed between 2001 and 2010, and followed-up for ≥ 4 years (median 8.04). Disease activity, cumulative articular/extra-articular damage and quality of life were evaluated by the assessment tools Juvenile Arthritis Disease Activity Score (JADAS71), Juvenile Arthritis Damage Index (JADI) and Childhood Health Assessment Questionnaire (CHAQ), respectively. Moreover, potential predictors of the disease progression and their relation to biologic therapy were investigated. High JADAS71 score (> 9) at diagnosis was indicative of progression to polyarticular course and the need for early introduction of biologic treatment. Other independent predictors of progression to polyarthritis, were: involvement of upper limb, hip and ankle within 6 months following JIA diagnosis and percentage of cumulative time with active disease > 35% within the first year. At the end of the study, both the median JADAS71 score and the Disability Index were significantly lower than the initial (p < 0.001) and remission off medication was achieved in 25% of the patients. Articular and extra-articular (only ocular) cumulative damage was demonstrated only in 5 and 7.5% of patients, respectively. Physical functional ability was found normal/mildly restricted in 93.3% and moderately restricted in 6.7% of the patients. We believe that these findings, fit in with a picture of JIA course and outcome under current conditions of objective “disease status” evaluation and of tightly controlled follow-up. Predictors emerged from our study could contribute to the identification of patients who will need early implementation of biologic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shenoi S (2017) Juvenile idiopathic arthritis—changing times, changing terms, changing treatments. Pediatr Rev 38:221–232

    Article  PubMed  Google Scholar 

  2. Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra B, Ravelli A (2016) Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther 3:187–207

    Article  PubMed  PubMed Central  Google Scholar 

  3. Guzman J, Oen K, Tucker LB et al (2015) The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the reACCh-out cohort. Ann Rheum Dis 74:1854–1860

    Article  PubMed  CAS  Google Scholar 

  4. Cimaz R, Marino A, Martini A (2017) How I treat juvenile idiopathic arthritis: a state of the art review. Autoimmun Rev 16:1008–1015

    Article  PubMed  Google Scholar 

  5. Consolaro A, Giancane G, Schiappapietra B et al (2016) Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 14:23

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hayward K, Wallace CA (2009) Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res Ther 11:216

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Webb K, Wedderburn L (2015) Advances in the treatment of polyarticular juvenile idiopathic arthritis. Curr Opin Rheumatol 27:505–510

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Wallace CA, Giannini EH, Spalding SJ et al (2012) Childhood arthritis and rheumatology research alliance. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheumatol 64:2012–2021

    Article  Google Scholar 

  9. Wallace CA (2010) Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology 49:1213–1214

    Article  PubMed  Google Scholar 

  10. Wallace CA, Ruperto N, Giannini EH (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31:2290–2294

    PubMed  Google Scholar 

  11. Magni-Manzoni S, Ruperto N, Pistorio A et al (2008) Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis Rheumatol (Arthritis Care Res) 59:1120–1127

    Article  Google Scholar 

  12. Lovell DJ, Ruperto N, Giannini EH, Martini A (2013) Advances from clinical trials in juvenile idiopathic arthritis. Nat Rev Rheumatol 9:557–563

    Article  PubMed  Google Scholar 

  13. Solari N, Viola S, Pistorio A et al (2008) Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary centre sample. Arthritis Rheumatol 59:1571–1579

    Article  Google Scholar 

  14. Adib N, Silman A, Thomson W (2005) Outcome following onset of juvenile idiopathic inflammatory arthritis. II. Predictors of outcome in juvenile arthritis. Rheumatology 44:1002–1007

    Article  PubMed  CAS  Google Scholar 

  15. Adib N, Silman A, Thomson W (2005) Outcome following onset of juvenile idiopathic inflammatory arthritis. I. Frequency of different outcomes. Rheumatology 44:995–1001

    Article  PubMed  CAS  Google Scholar 

  16. Oen K (2002) Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 16:347–360

    Article  PubMed  Google Scholar 

  17. Ravelli A (2004) Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin Exp Rheumatol 22:271–275

    PubMed  CAS  Google Scholar 

  18. Flato B, Lien G, Smerdel A et al (2003) Prognostic factors in juvenile rheumatoid arthritis: a case–control study revealing early predictors and outcome after 14.9 years. J Rheumatol 30:386–393

    PubMed  Google Scholar 

  19. Arguedas O, Fasth A, Anderson-Gare B (2002) A prospective population based study on outcome of juvenile chronic arthritis in Costa Rica. J Rheumatol 29:174–183

    PubMed  Google Scholar 

  20. Consolaro A, Van Dijkhuizen EHP, Espada G et al (2017) Development of new JADAS and cJADAS cut-offs for disease activity states in oligoarthritis and RF-negative polyarthritis from a large multinational cohort of children with juvenile idiopathic arthritis. Pediatr Rheumatol 12(Suppl 2):64

    Google Scholar 

  21. Swart JF, Van Dijkhuizen EHP, Wulffraat NM, De Roock S (2018) Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis 77:336–342

    Article  PubMed  Google Scholar 

  22. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T et al (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheumatol 63(9):2809–2818

    Article  Google Scholar 

  23. Pratsidou-Gertsi P, Vougiouka O, Tsitsami E et al (2001) Paediatric Rheumatology International Trials Organisation. The Greek version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19:S76–S80

    PubMed  CAS  Google Scholar 

  24. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392

    PubMed  Google Scholar 

  25. Consolaro A, Ruperto N, Bazsco A et al (2009) Development and validation of a Composite Disease Activity Score for juvenile idiopathic arthritis. Arthritis Rheumatol (Arthritis Care Res) 61:658–666

    Article  Google Scholar 

  26. Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, For the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Pediatric Rheumatology Collaborative Study Group (PRCSG), the Paediatric Rheumatology International Trials Organisation (PRINTO) (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63: 929–936

    Article  Google Scholar 

  27. Greek Rheumatology Society (2001) Greek Rheumatology Society’s recommendations for the treatment of rheumatic diseases with biologic agents (article in Greek). http://www.ere.gr/Pdf/eresystaseis.pdf. Accessed in 2001

  28. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, Morgan DeWitt E et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthitis Care Res 63:465–482

    Article  Google Scholar 

  29. Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y et al (2013) 2013 Update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res 65:1551–1563

    Article  Google Scholar 

  30. Cassidy J, Kivlin J, LindsIey C, Nocton J (2006) Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 117:1843–1845

    Article  PubMed  Google Scholar 

  31. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  32. Duffy CM (2005) Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. Pediatr Clin N Am 52:359–372

    Article  Google Scholar 

  33. Ruperto N, Ravelli A, Pistorio A, For the Paediatric Rheumatology International Trials Organisation (PRINTO) et al (2001) Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 19:S1–S9

    PubMed  CAS  Google Scholar 

  34. Magni-Manzoni S, Pistorio A, Labo E et al (2008) A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis. Ann Rheum Dis 67:1159–1164

    Article  PubMed  CAS  Google Scholar 

  35. Oen K, Tucker L, Huber A et al (2009) Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum (Arthritis Care Res) 61:1077–1086

    Article  Google Scholar 

  36. Glerup M, Herlin T, Twilt M (2017) Clinical outcome and long-term remission in JIA. Curr Rheumatol Rep 19:75. https://doi.org/10.1007/s11926-017-0702-4

    Article  PubMed  Google Scholar 

  37. Shoop-Worrall S, Kearsley-Fleet L, Thomson W, Verstappen S, Hyrich K (2017) How common is remission in juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheumatol 47(3):331–337

    Article  Google Scholar 

  38. Ravelli A, Consolaro A, Horneff G et al (2018) Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis 77(6):819–828

    PubMed  Google Scholar 

  39. Petty RE, Cassidy JT (2011) Textbook of pediatric rheumatology. Saunders Elsevier, Philadelphia

    Google Scholar 

  40. Marzetti V, Breda L, Miulli E, Filippetti F, Mancini C, Chiarelli F et al (2017) Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population based study. AnIg 29:281–292

    CAS  Google Scholar 

  41. Colbert RA (2010) Classification of juvenile spondyloarthritis: enthesitis-related arthritis and beyond. Nat Rev Rheumatol 6:477–485

    Article  PubMed  PubMed Central  Google Scholar 

  42. Angeles-Han ST, Pelajo CF, Vogler LB et al (2013) Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. J Rheumatol 40:2088–2096

    Article  PubMed  PubMed Central  Google Scholar 

  43. Moradi A, Amin RM, Thorne JE (2014) The role of gender in juvenile idiopathic arthritis-associated uveitis. J Ophthalmol 2014:461078

    Article  PubMed  PubMed Central  Google Scholar 

  44. Clarke S, Sen E, Ramanan A (2016) Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol 14:27

    Article  Google Scholar 

  45. Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21:180–191

    Article  PubMed  Google Scholar 

  46. Angeles-Han S, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K et al (2015) Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol 13:19

    Article  Google Scholar 

  47. Ravelli A, Felici E, Magni-Manzoni S et al (2005) Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheumatol 52:826–832

    Article  Google Scholar 

  48. Ravelli A, Varnier GC, Oliviera S et al (2011) Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheumatol 63:267–275

    Article  Google Scholar 

  49. Martini A (2012) It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 71:1437–1439

    Article  PubMed  Google Scholar 

  50. Guillaume S, Prieur AM, Coste J, Job-Deslandre C (2000) Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheumatol 43:1858–1865

    Article  CAS  Google Scholar 

  51. Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder ML, Cabral DA (2002) The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheumatol 46:2708–2715

    Article  Google Scholar 

  52. Sarma P, Misra R, Aggarwal A (2008) Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis. Clin Rheumatol 27:1261–1265

    Article  PubMed  Google Scholar 

  53. De Oliveira Sato J, Corrente JE, Saadmagalhaes C (2011) Progression of articular and extraarticular damage in oligoarticular juvenile idiopathic arthritis. Clin Exp Rheumatol 29:871–877

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Florentia Kanakoudi-Tsakalidou and Maria Trachana are equally contributed.

Authors and Affiliations

  1. First Department of Pediatrics, School of Medicine, Pediatric Immunology and Rheumatology Referral Center, Ippokration General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos St, 54642, Thessaloniki, Greece

    Panayiota Nalbanti, Florentia Kanakoudi-Tsakalidou, Maria Trachana, Polyxeni Pratsidou-Gertsi, Evangelia Farmaki & Fotios Papachristou

  2. Medical Education Informatics, Lab of Medical Physics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Panagiotis Bamidis

Authors
  1. Panayiota Nalbanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florentia Kanakoudi-Tsakalidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Trachana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Polyxeni Pratsidou-Gertsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Evangelia Farmaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Panagiotis Bamidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fotios Papachristou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study design: FKT, MT, PPG, PN. Follow-up and recruitment of patients: FKT, MT, PN, PPG. Patient data recording, electronically: PN. Analysis and interpretation of data: PN, FKT, MT, EF. Statistical analysis: PN, PB. Manuscript preparation: PN, FKT. Manuscript critical review: FKT, FP.

Corresponding author

Correspondence to Panayiota Nalbanti.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nalbanti, P., Kanakoudi-Tsakalidou, F., Trachana, M. et al. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment. Rheumatol Int 38, 1241–1250 (2018). https://doi.org/10.1007/s00296-018-4062-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-4062-9

Keywords

Search

Navigation